Introduction: PH & PG are rare neuroendocrine tumors treated with MIBG but protocols are not standardized and reported results are variable.
Aim(s): Outcomes after MIBG therapy vary as there is no set protocol as to the dose or number of cycles given. We report results of seven pts receiving MIBG therapy for metastatic PH/PG.
Materials and methods: Retrospectively study: seven pts receiving MIBG [M/F 6/1 median age 31 yr] with metastatic PH (n=4) or PG (n=3) to evaluate efficacy tolerability & overall survival. Response assessed using clinical benefit biochemical markers and radiology.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Medical treatment - Others
Presenting Author: Dr Zena Salih
To read results and conclusion, please login ...
Further abstracts you may be interested in